Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Contraception and Contraceptive Drugs

  Free Subscription

Articles published in Am J Obstet Gynecol

Retrieve available abstracts of 48 articles:
HTML format

Single Articles

    April 2023
  1. EDELMAN A, Boniface E, Schrote K, Messerle-Forbes M, et al
    Treatment of unfavorable bleeding patterns in contraceptive implant users: a randomized clinical trial of curcumin.
    Am J Obstet Gynecol. 2023 Apr 26:S0002-9378(23)00265.
    PubMed     Abstract available

    March 2023
    Extended use of the Levonorgestrel Intrauterine System for Contraception.
    Am J Obstet Gynecol. 2023 Mar 16:S0002-9378(23)00160.

  3. THURMAN AR, Moench TR, Hoke M, Politch JA, et al
    ZB-06, a vaginal film containing an engineered human contraceptive antibody (HC4-N), demonstrates safety and efficacy in a phase 1 postcoital test and safety study.
    Am J Obstet Gynecol. 2023 Mar 2:S0002-9378(23)00139.
    PubMed     Abstract available

    February 2023
  4. RODRIGUEZ MI, Meath T, Watson K, Daly A, et al
    Predicted changes in travel distance for abortion among counties with low rates of effective contraceptive use following Dobbs v Jackson.
    Am J Obstet Gynecol. 2023 Feb 2:S0002-9378(23)00072.

    December 2022
  5. MCCOLL R, Gifford K, Joan McDuffie M, Boudreaux M, et al
    Same-day long-acting reversible contraceptive utilization after a statewide contraceptive access initiative.
    Am J Obstet Gynecol. 2022 Dec 21:S0002-9378(22)02582.
    PubMed     Abstract available

  6. HEALY A, Davidson C, Allbert J, Bauer S, et al
    Telemedicine in obstetrics, quality and safety considerations.
    Am J Obstet Gynecol. 2022 Dec 5:S0002-9378(22)02261.
    PubMed     Abstract available

    November 2022
  7. KAISER JE, Turok DK, Gero A, Gawron LM, et al
    One-year pregnancy and continuation rates after placement of levonorgestrel or copper intrauterine devices for emergency contraception: A randomized controlled trial.
    Am J Obstet Gynecol. 2022 Nov 22:S0002-9378(22)02189.
    PubMed     Abstract available

    October 2022
  8. FELS LM, Costescu D, Vieira CS, Peipert JF, et al
    The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
    Am J Obstet Gynecol. 2022 Oct 29:S0002-9378(22)00835.
    PubMed     Abstract available

    September 2022
  9. SWAN LET, Cutler AS, Lands M, Schmuhl NB, et al
    Physician Beliefs about Contraceptive Methods as Abortifacients.
    Am J Obstet Gynecol. 2022 Sep 28. pii: S0002-9378(22)00772.

  10. JENSEN JT, Lukkari-Lax E, Schulze A, Wahdan Y, et al
    Contraceptive efficacy and safety of 52mg LNG-IUS for up to 8 years: findings from the Mirena Extension Trial.
    Am J Obstet Gynecol. 2022 Sep 9. pii: S0002-9378(22)00729.
    PubMed     Abstract available

    August 2022
  11. HOGMARK S, Lichtenstein Liljeblad K, Envall N, Gemzell-Danielsson K, et al
    Placement of an intrauterine device within 48 hours after early medical abortion - a randomized controlled trial.
    Am J Obstet Gynecol. 2022 Aug 12. pii: S0002-9378(22)00646.
    PubMed     Abstract available

  12. HENKEL A, Lerma K, Reyes G, Gutow H, et al
    Lactogenesis and breastfeeding after immediate versus delayed birth-hospitalization insertion of etonogestrel contraceptive implant: A non-inferiority trial.
    Am J Obstet Gynecol. 2022 Aug 11. pii: S0002-9378(22)00644.
    PubMed     Abstract available

    July 2022
  13. MILLER R, Gyamfi-Bannerman C
    Society for Maternal-Fetal Medicine Consult Series #63: Cesarean scar ectopic pregnancy.
    Am J Obstet Gynecol. 2022 Jul 15. pii: S0002-9378(22)00478.
    PubMed     Abstract available

    June 2022
  14. GOUETH RC, Maki KG, Babatunde A, Eden KB, et al
    Effects of Technology-Based Contraceptive Decision Aids: A Systematic Review and Meta-Analysis.
    Am J Obstet Gynecol. 2022 Jun 29. pii: S0002-9378(22)00526.
    PubMed     Abstract available

  15. TOFFOL E, Heikinheimo O, Jousilahti P, But A, et al
    Metabolomics profile of 5649 users and non-users of hormonal intrauterine devices in Finland.
    Am J Obstet Gynecol. 2022 Jun 10. pii: S0002-9378(22)00455.
    PubMed     Abstract available

  16. VAN BIEMA F, Friedman AM, Cepin AG, Wen T, et al
    Trends in Use of Long-Acting Reversible Contraception during Delivery Hospitalizations, 2000-2019.
    Am J Obstet Gynecol. 2022 Jun 3. pii: S0002-9378(22)00436.

    May 2022
  17. FANG NZ, Westhoff CL
    Update on Incidence of Inpatient Tubal Ligation and Long-acting Reversible Contraception in the United States.
    Am J Obstet Gynecol. 2022 May 12. pii: S0002-9378(22)00365.
    PubMed     Abstract available

  18. CREININ MD, Schreiber CA, Turok DK, Cwiak C, et al
    Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use.
    Am J Obstet Gynecol. 2022 May 12. pii: S0002-9378(22)00366.
    PubMed     Abstract available

    April 2022
  19. GATZ JL, Armstrong MA, Postlethwaite D, Raine-Bennett T, et al
    Association Between Intrauterine Device Type and Risk of Perforation and Device Expulsion: Results From the APEX-IUD Study.
    Am J Obstet Gynecol. 2022 Apr 5. pii: S0002-9378(22)00264.

    March 2022
  20. MONIZ MH, Peahl AF, Dawn Zinsser M, Kolenic MGE, et al
    Social Vulnerability and Utilization of Postpartum Long-acting Reversible Contraception and Sterilization.
    Am J Obstet Gynecol. 2022 Mar 18. pii: S0002-9378(22)00202.

  21. GETAHUN D, Fassett MJ, Gatz J, Armstrong MA, et al
    Association Between Menorrhagia and Risk of Intrauterine Device-Related Uterine Perforation and Device Expulsion: Results from the APEX-IUD Study.
    Am J Obstet Gynecol. 2022 Mar 12. pii: S0002-9378(22)00197.
    PubMed     Abstract available

  22. THORNTON M, Ascha MS, Arora KS
    Addressing Fluidity in Contraceptive Decision-Making: A Key Component of Patient-Centered Contraceptive Counseling.
    Am J Obstet Gynecol. 2022 Mar 3. pii: S0002-9378(22)00160.

    December 2021
  23. FANG NZ, Advaney SP, Castano PM, Davis A, et al
    Female Permanent Contraception Trends and Updates.
    Am J Obstet Gynecol. 2021 Dec 29. pii: S0002-9378(21)02956.
    PubMed     Abstract available

  24. RALPH LJ, Ehrenreich K, Barar R, Biggs MA, et al
    Accuracy of self-assessment of gestational duration among people seeking abortion.
    Am J Obstet Gynecol. 2021 Dec 16. pii: S0002-9378(21)02683.
    PubMed     Abstract available

  25. BURCHARDT NA, Eliassen AH, Shafrir AL, Rosner B, et al
    Oral contraceptive use by formulation and breast cancer risk by subtype in the Nurses' Health Study II: a prospective cohort study.
    Am J Obstet Gynecol. 2021 Dec 15. pii: S0002-9378(21)02686.
    PubMed     Abstract available

    October 2021
  26. KRAMER RD, Higgins JA, Everett B, Turok DK, et al
    A Prospective Analysis of the Relationship Between Sexual Acceptability and Contraceptive Satisfaction Over Time.
    Am J Obstet Gynecol. 2021 Oct 14. pii: S0002-9378(21)01109.
    PubMed     Abstract available

  27. MONIZ MH, Dalton VK, Smith RD, Owens LE, et al
    Feasibility and Acceptability of a Toolkit-Based Process to Implement Patient-Centered, Immediate Postpartum Long-Acting Reversible Contraception Services.
    Am J Obstet Gynecol. 2021 Oct 13. pii: S0002-9378(21)01110.
    PubMed     Abstract available

  28. HESTER RH, Hortobagyi GN, Lim B
    Inflammatory breast cancer: early recognition and diagnosis is critical.
    Am J Obstet Gynecol. 2021;225:392-396.
    PubMed     Abstract available

    August 2021
  29. CHEN C, Strasser J, Banawa R, Luo Q, et al
    Who is providing contraception care in the United States? An Observational Study of the Contraception Workforce.
    Am J Obstet Gynecol. 2021 Aug 18. pii: S0002-9378(21)00883.
    PubMed     Abstract available

    July 2021
  30. DE WIT AE, DE Vries YA, DE Boer MK, Scheper C, et al
    Efficacy of combined oral contraceptives for depressive symptoms and overall symptomatology in premenstrual syndrome: pairwise and network meta-analysis of randomized trials.
    Am J Obstet Gynecol. 2021 Jul 2. pii: S0002-9378(21)00774.
    PubMed     Abstract available

  31. RODRIGUEZ MI, Skye M, Edelman AB, Anderson L, et al
    Association of pharmacist prescription and 12 month contraceptive continuation rates.
    Am J Obstet Gynecol. 2021 Jul 1. pii: S0002-9378(21)00773.
    PubMed     Abstract available

    June 2021
  32. HARITON E, Shirazi TN, Douglas NC, Hershlag A, et al
    Anti-Mullerian hormone levels among contraceptive users: evidence from a cross-sectional cohort of 27,125 individuals.
    Am J Obstet Gynecol. 2021 Jun 11. pii: S0002-9378(21)00685.
    PubMed     Abstract available

    April 2021
  33. KAIMAL A, Norton ME
    Society for Maternal-Fetal Medicine Consult Series #55: Counseling women at increased risk of maternal morbidity and mortality.
    Am J Obstet Gynecol. 2021;224:B16-B23.
    PubMed     Abstract available

  34. YEE LM, Williams B, Green HM, Carmona-Barrera V, et al
    Bridging the postpartum gap: Best practices for training of obstetric patient navigators.
    Am J Obstet Gynecol. 2021 Apr 1. pii: S0002-9378(21)00218.
    PubMed     Abstract available

    March 2021
  35. MILLS K, Marchand G, Sainz K, Azadi A, et al
    Salpingectomy vs tubal ligation for sterilization: a systematic review and meta-analysis.
    Am J Obstet Gynecol. 2021;224:258-265.
    PubMed     Abstract available

    January 2021
  36. SCHRIJVER LH, Antoniou AC, Olsson H, Mooij TM, et al
    Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.
    Am J Obstet Gynecol. 2021 Jan 22. pii: S0002-9378(21)00038.
    PubMed     Abstract available

    December 2020
  37. MERZ AA, Gutierrez-Sacristan A, Bartz D, Williams NE, et al
    Population attitudes toward contraceptive methods over time on a social media platform.
    Am J Obstet Gynecol. 2020 Dec 9. pii: S0002-9378(20)31378.
    PubMed     Abstract available

  38. RUSSELL CB, Evans ML, Qasba N, Frankel A, et al
    Medicaid sterilization consent forms: variation in rejection and payment consequences.
    Am J Obstet Gynecol. 2020;223:934-936.

    November 2020
  39. GO VAA, Thomas MC, Singh B, Prenatt S, et al
    A systematic review of the psychosocial impact of fibroids before and after treatment.
    Am J Obstet Gynecol. 2020;223:674-708.
    PubMed     Abstract available

    October 2020
  40. JOULAUD P, Pithois A, Ramanah R
    Am J Obstet Gynecol. 2020 Oct 13. pii: S0002-9378(20)31185.

  41. SCHULTHEIS P, Natalie Montoya M, Zhao Q, Archer J, et al
    Contraception and Ectopic Pregnancy Risk: A Prospective Observational Analysis.
    Am J Obstet Gynecol. 2020 Oct 10. pii: S0002-9378(20)31187.
    PubMed     Abstract available

  42. CHUNG YS, Woo HY, Lee JY, Park E, et al
    Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer.
    Am J Obstet Gynecol. 2020 Oct 8. pii: S0002-9378(20)31175.
    PubMed     Abstract available

    September 2020
  43. BEDFORD L, Parker SE, Davis E, Salzman E, et al
    Characteristics of the vaginal microbiome in women with and without clinically confirmed vulvodynia.
    Am J Obstet Gynecol. 2020;223:406.
    PubMed     Abstract available

  44. SONG X, Wu J, Zhou Y, Feng L, et al
    Reproductive and hormonal factors and risk of cognitive impairment among Singapore Chinese women.
    Am J Obstet Gynecol. 2020;223:410.
    PubMed     Abstract available

    August 2020
  45. WESTIN SN, Fellman B, Sun CC, Broaddus RR, et al
    Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial Cancer.
    Am J Obstet Gynecol. 2020 Aug 14. pii: S0002-9378(20)30861.
    PubMed     Abstract available

  46. BEELEN P, VAN DEN Brink MJ, Herman MC, Geomini PM, et al
    Levonorgestrel releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding.
    Am J Obstet Gynecol. 2020 Aug 11. pii: S0002-9378(20)30844.
    PubMed     Abstract available

    April 2020
  47. SONALKAR S, Koelper N, Creinin MD, Atrio JM, et al
    Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of success from a randomized trial.
    Am J Obstet Gynecol. 2020 Apr 16. pii: S0002-9378(20)30431.
    PubMed     Abstract available

    January 2020
  48. MILLER R, Timor IE, Gyamfi-Bannerman C
    Society for Maternal-Fetal Medicine (SMFM) Consult Series #49: Cesarean scar pregnancy.
    Am J Obstet Gynecol. 2020 Jan 20. pii: S0002-9378(20)30038.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Contraception and Contraceptive Drugs is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.